Major Depressive Disorder
📧 Sign up to get email alerts when something new happens for Major Depressive Disorder.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2015-06-25FDA Approved: ESCITALOPRAM — Supplemental Application (Lupin Pharmaceuticals, Inc.)
FDA approved Lupin Pharmaceuticals' supplemental application for escitalopram (generic) under an ANDA, confirming the availability of a gene…
-
CLINICAL_TRIALS trial_result · 2015-06-25Clinical Trial Update: An Interventional Study of Geriatric Frailty, Osteoporosis, and Depression [NA]
The interventional study in Taiwan examining frailty, osteoporosis, and depression has completed.
-
CLINICAL_TRIALS trial_result · 2015-06-24Clinical Trial Update: Telemedicine for Improved Delivery of Psychosocial Treatments for Post Traumatic Stress Disorder [NA]
A completed clinical trial evaluating the use of telemedicine to deliver psychosocial treatments for post-traumatic stress disorder and rela…
-
CLINICAL_TRIALS trial_result · 2015-06-24Clinical Trial Update: The Effect of Patient and Investigator Expectation on the Efficacy of Escitalopram in the Treatment Depression [NA]
A completed clinical trial investigates how patient and investigator expectations influence the efficacy of escitalopram in treating major d…
-
CLINICAL_TRIALS trial_result · 2015-06-19Clinical Trial Update: Melatonin Agonist Effects of Tasimelteon Versus Placebo in Patients With Major Depressive Disorder [Phase 2, Phase 3]
A phase 2/3 clinical trial evaluating tasimelteon, a melatonin receptor agonist, versus placebo in adults with major depressive disorder has…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2015-06-19Clinical Trial Update: Peripheral Plasma Micro-RNA and Proteomics Mapping in Depressive Patients, Treated With SSRI Medications
A terminated clinical trial investigating peripheral plasma micro-RNA and proteomics profiles in patients with depression who were treated w…
-
FDA approval · 2015-06-17FDA Approved: MIRTAZAPINE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
The FDA approved a supplemental application for mirtazapine submitted by Sun Pharmaceutical Industries, Inc.
-
CLINICAL_TRIALS trial_result · 2015-06-16Clinical Trial Update: Minimal Psychological Intervention in Diabetes Patients [NA]
A completed clinical trial evaluating a minimal psychological intervention in patients with type 2 diabetes and major depressive disorder. T…
-
CLINICAL_TRIALS research · 2015-06-16Clinical Trial Update: Multimedia Educational Program for Patients With Early-Stage Prostate Cancer or Breast Cancer [NA]
A completed clinical trial testing a multimedia educational program for patients with early-stage prostate cancer or breast cancer, includin…
-
CLINICAL_TRIALS trial_result · 2015-06-16Clinical Trial Update: A Study of JNJ-40411813 as Supplementary Treatment to an Antidepressant in Adults With Depression and Anxiety Symptoms [Phase 2]
A Phase 2 study evaluating JNJ-40411813 as supplementary treatment to an antidepressant in adults with Major Depressive Disorder has complet…
-
CLINICAL_TRIALS trial_result · 2015-06-16Clinical Trial Update: Switching to Duloxetine to Ameliorate SSRI-Induced Sexual Dysfunction [Phase 4]
Phase 4 trial investigating switching to duloxetine to alleviate SSRI-induced sexual dysfunction in individuals with depression; the study w…
-
FDA approval · 2015-06-15FDA Approved: TRAZODONE HYDROCHLORIDE — Supplemental Application (Oxford Pharmaceuticals, LLC)
FDA approved a supplemental application for trazodone hydrochloride from Oxford Pharmaceuticals, LLC, indicating an approved modification to…
-
CLINICAL_TRIALS research · 2015-06-15Clinical Trial Update: Epidemiology of Depression, Anxiety, and Cognitive Impairment
A completed observational epidemiology study on Depression, Anxiety, and Cognitive Impairment with results posted in 2015.
-
FDA approval · 2015-06-14FDA Approved: BUPROPION HYDROCHLORIDE SR — Supplemental Application (Actavis Pharma, Inc.)
FDA approved a supplemental application for Bupropion hydrochloride sustained-release (Actavis) to continue marketing the generic product.
-
CLINICAL_TRIALS trial_result · 2015-06-12Clinical Trial Update: Treatment for Depressed Preadolescent Girls [Phase 1]
A Phase 1 trial evaluating a treatment for depression in preadolescent girls has completed. The study was conducted by the University of Tex…
-
FDA approval · 2015-06-11FDA Approved: VIIBRYD — Supplemental Application (Allergan, Inc.)
The FDA has approved Allergan's supplemental application for VIIBRYD (vilazodone hydrochloride), granting approval for the requested change …
-
CLINICAL_TRIALS trial_result · 2015-06-10Clinical Trial Update: Study of Exercise to Manage Distress During Breast Screening [Phase 2]
A Phase 2 study evaluating an exercise program to reduce distress during breast cancer screening has completed.
-
CLINICAL_TRIALS trial_result · 2015-06-10Clinical Trial Update: Motivational Interviewing to Reduce Substance Use Among Depression Patients [NA]
A completed clinical trial evaluating motivational interviewing to reduce substance use in patients with depression.
-
FDA approval · 2015-06-09FDA Approved: SERTRALINE HYDROCHLORIDE — Supplemental Application (Quallent Pharmaceuticals Health LLC)
FDA approved a supplemental application for sertraline hydrochloride (generic) from Quallent Pharmaceuticals Health LLC under ANDA077397.
-
CLINICAL_TRIALS trial_result · 2015-06-08Clinical Trial Update: Mindful Movement Program in Improving Quality of Life in Older Female Breast Cancer Survivors [NA]
Completed clinical trial evaluating a Mindful Movement Program to improve quality of life and psychosocial outcomes in older female breast c…
-
FDA approval · 2015-06-05FDA Approved: FETZIMA — Supplemental Application (Allergan, Inc.)
The FDA approved a supplemental application for FETZIMA (levomilnacipran hydrochloride) from Allergan, Inc.
-
CLINICAL_TRIALS trial_result · 2015-06-04Clinical Trial Update: Cognitive Therapy in Reducing Depression in Patients With Cancer [Phase 2]
This Phase 2 clinical trial evaluated cognitive therapy to reduce depression in cancer patients and has completed.
-
CLINICAL_TRIALS trial_result · 2015-06-03Clinical Trial Update: Clinical Trials of Three Non-Drug Treatments for Winter Depression (SAD) [NA]
A completed update on three non-drug treatment trials for Seasonal Affective Disorder (winter depression).
-
CLINICAL_TRIALS trial_result · 2015-06-02Clinical Trial Update: The Effectiveness of Sertraline in Patients Who Have Had Inadequate Response to Escitalopram [Phase 3]
This completed Phase 3 trial evaluated the effectiveness of sertraline in adults with major depressive disorder who had an inadequate respon…
-
FDA approval · 2015-06-02FDA Approved: TRAZODONE HYDROCHLORIDE — Supplemental Application (Apotex Corp)
FDA approved a supplemental application for trazodone hydrochloride submitted by Apotex Corp.